Gert Storm Selected Research

Polymers

11/2023	CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy.
6/2020	Systematic evaluation of design features enables efficient selection of Π electron-stabilized polymeric micelles.
1/2019	Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.
1/2018	Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information.
1/2018	Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.
4/2016	Locoregional cancer therapy using polymer-based drug depots.
3/2014	Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes.
1/2014	Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.
10/2012	Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles.
7/2012	Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gert Storm Research Topics

Disease

144	Neoplasms (Cancer) 04/2024 - 02/2002
33	Inflammation (Inflammations) 01/2023 - 01/2002
15	Arthritis (Polyarthritis) 01/2018 - 01/2002
13	Experimental Arthritis 01/2018 - 08/2002
12	Hyperthermia 03/2024 - 02/2007
12	Fibrosis (Cirrhosis) 01/2021 - 01/2012
11	Carcinoma (Carcinomatosis) 01/2018 - 07/2002
10	Melanoma (Melanoma, Malignant) 01/2023 - 02/2005
9	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 01/2015
8	Atherosclerosis 01/2023 - 12/2010
8	Rheumatoid Arthritis 07/2015 - 01/2005
7	Hypersensitivity (Allergy) 01/2022 - 05/2013
6	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2012
6	Atherosclerotic Plaque (Atheroma) 01/2023 - 12/2010
6	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2010
5	Liver Diseases (Liver Disease) 12/2020 - 01/2015
5	Experimental Melanoma 01/2019 - 06/2006
4	Triple Negative Breast Neoplasms 03/2024 - 07/2020
4	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2017
4	Disease Progression 01/2021 - 05/2006
4	Multiple Myeloma 10/2020 - 11/2010
4	Infections 01/2020 - 02/2002
4	Lung Neoplasms (Lung Cancer) 11/2018 - 12/2010
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2014
3	Thrombosis (Thrombus) 06/2020 - 10/2018
3	Necrosis 01/2020 - 08/2003
3	Hypoxia (Hypoxemia) 06/2019 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 03/2008 - 02/2002
2	Pathologic Neovascularization 11/2023 - 05/2006

Drug/Important Bio-Agent (IBA)

88	Liposomes (Liposome)IBA 03/2024 - 01/2002
20	GlucocorticoidsIBA 01/2019 - 01/2002
18	PolymersIBA 11/2023 - 11/2003
17	prednisolone phosphate FDA LinkGeneric 01/2022 - 07/2003
16	MicellesIBA 01/2023 - 10/2010
16	AntigensIBA 01/2022 - 01/2005
14	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 08/2003
12	LigandsIBA 11/2023 - 11/2004
10	Small Interfering RNA (siRNA)IBA 10/2021 - 11/2004
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
10	Prednisolone (Predate)FDA LinkGeneric 12/2016 - 08/2003
9	Therapeutic UsesIBA 01/2023 - 01/2003
9	Peptides (Polypeptides)IBA 01/2021 - 10/2004
9	Drug CarriersIBA 01/2019 - 02/2002
9	ErbB Receptors (EGF Receptor)IBA 10/2013 - 07/2002
7	liposomal doxorubicin (Doxil)FDA Link 03/2024 - 08/2003
6	hydroxypropyl methacrylateIBA 01/2013 - 12/2005
5	CollagenIBA 01/2023 - 08/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2005
5	ProdrugsIBA 01/2022 - 03/2003
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2014
5	methacrylamideIBA 10/2018 - 03/2008
5	IntegrinsIBA 01/2018 - 11/2004
5	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2008 - 07/2003
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2010
4	LipidsIBA 01/2023 - 04/2011
4	EnzymesIBA 01/2023 - 03/2003
4	Apolipoproteins E (ApoE)IBA 01/2023 - 04/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2015
4	SteroidsIBA 01/2022 - 09/2011
4	Complement System Proteins (Complement)IBA 01/2022 - 12/2014
4	Docetaxel (Taxotere)FDA Link 06/2021 - 01/2016
4	Lactic Acid (Lactate)FDA LinkGeneric 12/2020 - 10/2010
4	Gemcitabine FDA Link 01/2020 - 07/2009
4	Phosphates (Orthophosphate)IBA 01/2018 - 09/2006
4	Contrast MediaIBA 03/2017 - 12/2005
4	MicroRNAs (MicroRNA)IBA 12/2016 - 08/2014
4	monomethoxypolyethylene glycol (MPEG)IBA 01/2015 - 10/2010
4	RhodaminesIBA 02/2012 - 04/2011
3	AntibodiesIBA 01/2022 - 07/2012
3	VaccinesIBA 01/2022 - 10/2013
3	GlucuronidaseIBA 01/2022 - 03/2003
3	Transferrin (beta 2 Transferrin)IBA 10/2021 - 01/2019
3	Phosphotransferases (Kinase)IBA 03/2020 - 04/2012
3	CytokinesIBA 10/2019 - 01/2002
3	dexamethasone 21-phosphate FDA LinkGeneric 01/2019 - 04/2006
3	CholesterolIBA 09/2018 - 11/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 12/2010
3	ApolipoproteinsIBA 09/2017 - 04/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2004
3	Oxygen (Dioxygen)IBA 09/2014 - 11/2010
3	arginyl-glycyl-aspartic acidIBA 02/2014 - 11/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 08/2003
3	Ethylene Glycol (Monoethylene Glycol)IBA 07/2011 - 10/2010
3	Monoclonal AntibodiesIBA 07/2010 - 03/2003
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024 - 01/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 01/2016

Therapy/Procedure

65	Therapeutics 03/2024 - 07/2003
12	Intravenous Administration 01/2023 - 07/2003
12	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
6	Injections 01/2023 - 07/2003
6	Intravenous Injections 01/2020 - 10/2006
6	Radiotherapy 06/2019 - 02/2007
5	Microbubbles 10/2021 - 10/2012
5	Immunotherapy 07/2020 - 11/2010
4	Aftercare (After-Treatment) 03/2024 - 07/2003
4	Lasers (Laser) 01/2022 - 02/2012
4	Precision Medicine 01/2019 - 06/2011
2	Photochemotherapy (Photodynamic Therapy) 04/2024 - 01/2016
2	Oral Administration 01/2023 - 03/2011